AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Oct 23, 2015

34983_dirs_2015-10-22_a915a4d4-5b75-4a03-b4fc-1fd7e8770f25.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-21	Common Shares	P	2000	$0.183	Acquired	5918596	Direct
2015-10-21	Common Shares	P	1500	$0.1845	Acquired	5920096	Direct
2015-10-21	Common Shares	P	5000	$0.179	Acquired	5925096	Direct
2015-10-21	Common Shares	P	4000	$0.185	Acquired	5929096	Direct
2015-10-21	Common Shares	P	1500	$0.19	Acquired	5930596	Direct
2015-10-21	Common Shares	P	5000	$0.181	Acquired	5935596	Direct
2015-10-22	Common Shares	P	4000	$0.179	Acquired	5939596	Direct
2015-10-22	Common Shares	P	2750	$0.1789	Acquired	5942346	Direct
2015-10-22	Common Shares	P	2000	$0.18	Acquired	5944346	Direct
2015-10-22	Common Shares	P	4360	$0.175	Acquired	5948706	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	5916596	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect